Drugs / ABT-SLV176
last change Jun 2015 re-read 3 minutes ago

ABT-SLV176

Developed for
hypogonadism
Investigated by
AbbVie

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02082197 Mar 2014 → Jun 2015 hypogonadism AbbVie Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ABT-SLV176 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02082197 ↗